المؤلفون: Kennedy VE; Division of Blood and Marrow Transplantation, Stanford University School of Medicine, Stanford, California. Electronic address: vek@stanford.edu., Sahaf B; Division of Blood and Marrow Transplantation, Stanford University School of Medicine, Stanford, California., Wu F; Division of Blood and Marrow Transplantation, Stanford University School of Medicine, Stanford, California., Ehlinger ZJ; Division of Blood and Marrow Transplantation, Stanford University School of Medicine, Stanford, California., Arai S; Division of Blood and Marrow Transplantation, Stanford University School of Medicine, Stanford, California., Miklos DB; Division of Blood and Marrow Transplantation, Stanford University School of Medicine, Stanford, California.

المصدر: Transplantation and cellular therapy [Transplant Cell Ther] 2024 May; Vol. 30 (5), pp. 518.e1-518.e13. Date of Electronic Publication: 2024 Mar 06.

نوع المنشور: Journal Article; Clinical Trial, Phase II; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101774629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-6367 (Electronic) Linking ISSN: 26666367 NLM ISO Abbreviation: Transplant Cell Ther Subsets: MEDLINE

مواضيع طبية MeSH: Rituximab*/therapeutic use , Hematopoietic Stem Cell Transplantation*/adverse effects , B-Lymphocytes*/immunology , B-Lymphocytes*/drug effects , Graft vs Host Disease*/prevention & control , Graft vs Host Disease*/immunology , Immune Reconstitution*, Humans ; Female ; Male ; Middle Aged ; Adult ; Transplantation, Homologous/adverse effects ; Treatment Outcome ; Aged ; Follow-Up Studies

المؤلفون: Good Z; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.; Department of Biomedical Data Science, Stanford University School of Medicine, Stanford, CA, USA.; Parker Institute for Cancer Immunotherapy, Stanford University School of Medicine, Stanford, CA, USA., Spiegel JY; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.; Department of Medicine, Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA.; Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA., Sahaf B; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA., Malipatlolla MB; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA., Ehlinger ZJ; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA., Kurra S; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.; Homer Stryker M.D. School of Medicine, Western Michigan University, Kalamazoo, MI, USA., Desai MH; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA., Reynolds WD; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA., Wong Lin A; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.; Cancer Research Lab, Flow Cytometry Core Facility, University of California, Berkeley, Berkeley, CA, USA., Vandris P; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA., Wu F; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA., Prabhu S; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA., Hamilton MP; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.; Department of Medicine, Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA., Tamaresis JS; Department of Biomedical Data Science, Stanford University School of Medicine, Stanford, CA, USA., Hanson PJ; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.; Department of Medicine, Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA., Patel S; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.; Laboratory for Cell and Gene Medicine, Stanford University School of Medicine, Stanford, CA, USA.; Syncopation Life Sciences, San Mateo, CA, USA., Feldman SA; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.; Laboratory for Cell and Gene Medicine, Stanford University School of Medicine, Stanford, CA, USA., Frank MJ; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.; Department of Medicine, Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA., Baird JH; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.; Department of Medicine, Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA.; Department of Hematology and Hematopoietic Cell Transplantation, Division of Lymphoma, City of Hope National Medical Center, Duarte, CA, USA., Muffly L; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.; Department of Medicine, Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA., Claire GK; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.; Department of Medicine, Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA., Craig J; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.; Department of Medicine, Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA.; School of Medicine and Public Health, University of Wisconsin, Madison, WI, USA., Kong KA; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA., Wagh D; Stanford Genomics Facility, Stanford University School of Medicine, Stanford, CA, USA., Coller J; Stanford Genomics Facility, Stanford University School of Medicine, Stanford, CA, USA., Bendall SC; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.; Parker Institute for Cancer Immunotherapy, Stanford University School of Medicine, Stanford, CA, USA.; Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA., Tibshirani RJ; Department of Biomedical Data Science, Stanford University School of Medicine, Stanford, CA, USA.; Department of Statistics, Stanford University, Stanford, CA, USA., Plevritis SK; Department of Biomedical Data Science, Stanford University School of Medicine, Stanford, CA, USA.; Department of Radiology, Stanford University School of Medicine, Stanford, CA, USA., Miklos DB; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA. dmiklos@stanford.edu.; Department of Medicine, Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA. dmiklos@stanford.edu., Mackall CL; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA. cmackall@stanford.edu.; Parker Institute for Cancer Immunotherapy, Stanford University School of Medicine, Stanford, CA, USA. cmackall@stanford.edu.; Department of Medicine, Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA. cmackall@stanford.edu.; Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, USA. cmackall@stanford.edu.

المصدر: Nature medicine [Nat Med] 2022 Sep; Vol. 28 (9), pp. 1860-1871. Date of Electronic Publication: 2022 Sep 12.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE

مواضيع طبية MeSH: Neurotoxicity Syndromes*/etiology , Receptors, Chimeric Antigen*, Antigens, CD19 ; Humans ; Immunotherapy, Adoptive/adverse effects ; Immunotherapy, Adoptive/methods ; Lactate Dehydrogenases ; Proteomics ; Receptors, Antigen, T-Cell